Anticancer drug reveals alternate means of inducing cell suicide

Derivatives of the COX-2 inhibitor celecoxib can trigger cancer cell suicide, or apoptosis, but not necessarily through the recognized means of blocking COX-2 enzyme activity, a new study concludes. By separating COX-2 activity from apoptosis, researchers have a starting point for designing new classes of anticancer drugs, write Xueqin Song, Ching-Shih Chen, Ph.D., Ohio State University, and their coworkers in the April 17 issue of the Journal of the National Cancer Institute.

Celecoxib, an anti-inflammation pill for arthritis, is being studied for its potential in preventing and treating certain cancers. In a large percentage of tumors, the COX-2 enzyme is elevated, say Ernest T. Hawk, M.D., M.P.H., of the National Cancer Institute, and his coworkers in an accompanying editorial. They point out that past studies have shown that decreasing levels of COX-2 can suppress the growth of tumors. However, it has been unclear whether celecoxibs anticancer effects depend on COX-2 inhibition alone.

To find out, Chen and his coworkers created prostate cancer cells lacking the COX-2 enzyme. In contrast to the effects of COX-2 inhibitors such as celecoxib, which induce cell death, cells that lacked COX-2 remained alive. Exposure of these cells lacking COX-2 to various COX-2 inhibitors did lead to cell death. Whats more, derivatives of celecoxib that did not block COX-2 activity also caused cell death.

The authors note that these events were associated not with levels of COX-2 but with decreased phosphorylation of Akt and ERK2 proteins. This mode of action differs from that of conventional anticancer drugs, they point out.

In the accompanying editorial, Hawk and his colleagues note that celecoxib is being tested for the treatment and prevention of colon cancer and that newer generations of COX-2 inhibitors could prove to be safer and more effective.

However, they point out that the current findings are based on concentrations of c

Contact: Linda Wang
Journal of the National Cancer Institute

Page: 1 2

Related biology news :

1. Anticancer drug zebularine specifically targets tumor cells
2. The Bodys Anticancer Weaponry Backfires In Old Age
3. Enzymes "Magic" May Hold Key to Anticancer and Antimicrobial Drugs
4. Hidden diversity: DNA barcoding reveals a common butterfly is actually 10 different species
5. Brown research reveals key insight into memory-making
6. Study reveals why eyes in some paintings seem to follow viewers
7. New dye directly reveals activated proteins in living cells
8. Study reveals first genetic step necessary for prostate cancer growth
9. Study of flu patients reveals virus outsmarting key drug
10. Study in Science reveals recreational fishing takes big bite of ocean catch
11. Plumbing trees plumbing reveals their engineering skill

Post Your Comments:
TAG: Anticancer drug reveals alternate means inducing cell suicide

(Date:9/2/2015)... Sept. 2, 2015 About hand geometry biometrics ... banks, government organizations, telecommunication and hospitals as well as ... badges, and numeric keypads are used to prevent unauthorised ... palm and fingers of an individual, width of the ... with infrared light and reflectors can be used for ...
(Date:8/31/2015)... August 31, 2015 Growing need ... in government digitization projects to drive India ... published TechSci Research report, " India Biometrics Market Forecast & ... is projected to grow at a CAGR of over ... anticipated on account of extensive use of biometric technology in ...
(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
Breaking Biology News(10 mins):Global Hand Geometry Biometrics Market 2015-2019 2Global Hand Geometry Biometrics Market 2015-2019 3India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3
(Date:10/1/2015)... Oct. 1, 2015  xG Health Solutions, a ... xghealth.com, a new platform for communication and collaboration ... health systems and health plans improve the quality ... xG Health solutions, products and educational resources. ... and, as clinicians, we know the process of ...
(Date:10/1/2015)... ... October 01, 2015 , ... USDM Life Sciences , a ... it was selected by FDA to develop and implement a program for the Drug ... with FDA on this critical initiative for the life science and healthcare industries,” said ...
(Date:9/30/2015)... ... 2015 , ... Cambridge Semantics, the leading provider ... joined the Google for Work Partner Program as a Google Cloud Platform Technology ... dynamic infrastructures and this relationship allows the company to extend its robust smart ...
(Date:9/30/2015)... TORONTO , Sept. 30, 2015 Generex ... that it has entered into a non-binding Letter of ... www.rapid123.com ), a Florida company ... The LOI contemplates that Generex will acquire ... a purchase price of US$15,000,000 to be paid in ...
Breaking Biology Technology:xG Health Solutions Launches New Platform for Hospitals, Clinics and Health Plans 2USDM Life Sciences Chosen by FDA to Assess Pharmaceutical Readiness for Drug Supply Chain Security Act 2Cambridge Semantics Joins ‘Google for Work Partner Program’ as Cloud Platform Partner 2Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems 2Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems 3Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems 4Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems 5Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems 6
Cached News: